Literature DB >> 17915076

Treatment of patients comorbid for addiction and other psychiatric disorders.

Kathleen T Brady1, Marcia L Verduin, Bryan K Tolliver.   

Abstract

Psychiatric disorders and drug and alcohol use disorders commonly co-occur. A growing literature has documented the epidemiology and effects on the course of illness of comorbid psychiatric and substance use disorders (SUDs). Advances in treatment of co-occurring illnesses have progressed more slowly. The current article reviews recent developments in the diagnosis and treatment of co-occurring psychiatric disorders and SUDs with particular focus on psychotic disorders, affective disorders, anxiety disorders, personality disorders, and attention-deficit/hyperactivity disorder. Current treatment options and implications for future research are highlighted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915076     DOI: 10.1007/s11920-007-0048-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  47 in total

1.  Intranasal quetiapine abuse.

Authors:  Joseph M Pierre; Igor Shnayder; Donna A Wirshing; William C Wirshing
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

2.  Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use.

Authors:  David A Smelson; Sandra L Tunis; Allen W Nyhuis; Douglas E Faries; Bruce J Kinon; Haya Ascher-Svanum
Journal:  J Clin Psychopharmacol       Date:  2006-12       Impact factor: 3.153

3.  A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.

Authors:  Roger D Weiss; Margaret L Griffin; Monika E Kolodziej; Shelly F Greenfield; Lisa M Najavits; Dennis C Daley; Heidi Ray Doreau; John A Hennen
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

4.  Aripiprazole in schizophrenia with cocaine dependence: a pilot study.

Authors:  Thomas P Beresford; Lori Clapp; Brandon Martin; John L Wiberg; Julie Alfers; Henry F Beresford
Journal:  J Clin Psychopharmacol       Date:  2005-08       Impact factor: 3.153

5.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

6.  Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.

Authors:  Elizabeth B Stuyt; Terrie A Sajbel; Michael H Allen
Journal:  Am J Addict       Date:  2006 Mar-Apr

7.  A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Authors:  Alan S Bellack; Melanie E Bennett; Jean S Gearon; Clayton H Brown; Ye Yang
Journal:  Arch Gen Psychiatry       Date:  2006-04

8.  The role of psychiatric disorders in predicting drug dependence treatment outcomes.

Authors:  Wilson M Compton; Linda B Cottler; Jacqueline L Jacobs; Arbi Ben-Abdallah; Edward L Spitznagel
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

9.  Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.

Authors:  Ismene L Petrakis; Stephanie O'Malley; Bruce Rounsaville; James Poling; Colette McHugh-Strong; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

10.  The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial.

Authors:  Kenneth M Carpenter; Adam C Brooks; Suzanne K Vosburg; Edward V Nunes
Journal:  Drug Alcohol Depend       Date:  2004-05-10       Impact factor: 4.492

View more
  17 in total

Review 1.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

2.  Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects.

Authors:  Robert W Gould; Russell J Amato; Michael Bubser; Max E Joffe; Michael T Nedelcovych; Analisa D Thompson; Hilary H Nickols; Johannes P Yuh; Xiaoyan Zhan; Andrew S Felts; Alice L Rodriguez; Ryan D Morrison; Frank W Byers; Jerri M Rook; John S Daniels; Colleen M Niswender; P Jeffrey Conn; Kyle A Emmitte; Craig W Lindsley; Carrie K Jones
Journal:  Neuropsychopharmacology       Date:  2015-08-28       Impact factor: 7.853

3.  Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.

Authors:  Millie Rincón-Cortés; Kimberly G Gagnon; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-18       Impact factor: 7.853

4.  A single episode of maternal deprivation impairs the motivation for cocaine in adolescent mice.

Authors:  Mariangela Martini; Olga Valverde
Journal:  Psychopharmacology (Berl)       Date:  2011-06-25       Impact factor: 4.530

Review 5.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

Review 6.  The role of the orbitofrontal cortex in alcohol use, abuse, and dependence.

Authors:  David E Moorman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-02-09       Impact factor: 5.067

7.  Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

8.  Acute stress worsens the deficits in appetitive behaviors for social and sexual stimuli displayed by rats after long-term withdrawal from morphine.

Authors:  Yunjing Bai; David Belin; Xigeng Zheng; Zhengkui Liu; Yue Zhang
Journal:  Psychopharmacology (Berl)       Date:  2017-03-09       Impact factor: 4.530

Review 9.  From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?

Authors:  I S McGregor; P D Callaghan; G E Hunt
Journal:  Br J Pharmacol       Date:  2008-05       Impact factor: 8.739

10.  The Alcohol Use Disorders Identification Test (AUDIT): reliability and validity of the Greek version.

Authors:  George Moussas; Georgia Dadouti; Athanassios Douzenis; Evangelos Poulis; Athanassios Tzelembis; Dimitris Bratis; Christos Christodoulou; Lefteris Lykouras
Journal:  Ann Gen Psychiatry       Date:  2009-05-14       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.